Three OMRF scientists were recognized for excellence at this year’s American College of Rheumatology meeting.
As a physician-scientist, Matlock Jeffries will maintain a lab focused on osteoarthritis and will see patients in the foundation’s Rheumatology Center of Excellence.
Multiple studies have show the drug is not effective at treating COVID-19, and in some cases can even cause heart problems.
The findings will allow for more targeted treatment approaches.
Morris Reichlin helped build OMRF into one of the world’s leading centers for lupus research and treatment.
The award is for continued research into the origins of Sjögren’s syndrome.